ArticleInternational journal of experimental pathology2022

High level of FHL2 exacerbates the outcome of non-small cell lung cancer (NSCLC) patients and the malignant phenotype in NSCLC cells.

Na Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.